MedPath

Lobaplatin

Generic Name
Lobaplatin
Drug Type
Small Molecule
Chemical Formula
C9H18N2O3Pt
CAS Number
135558-11-1
Unique Ingredient Identifier
OX5XK1JD8C

Overview

Lobaplatin has been used in trials studying the treatment of Breast Cancer, Hepatocellular Carcinoma, and Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma.

Indication

主要用于治疗乳腺癌、小细胞肺癌及慢性粒细胞白血病。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/12/03
Phase 2
Recruiting
2023/12/14
Phase 2
Recruiting
2023/03/22
Phase 3
Not yet recruiting
Sun Yat-sen University
2023/03/13
Phase 3
Recruiting
Zhujiang Hospital
2023/01/27
Phase 3
Recruiting
Zhujiang Hospital
2022/09/19
Phase 2
Recruiting
2021/04/15
Phase 2
Not yet recruiting
Wuhan Union Hospital, China
2021/03/22
Phase 2
Recruiting
Wuhan Union Hospital, China
2018/10/09
Phase 2
UNKNOWN
The First Affiliated Hospital of Guangzhou Medical University
2018/01/29
Phase 4
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Lobaplatin for Injection
国药准字H20080359
化学药品
注射剂
5/12/2020
Lobaplatin for Injection
国药准字H20050308
化学药品
注射剂
5/12/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.